Evidence map›Paper›PMID 32558327›Full record

ArticleESC heart failure2020

B-type natriuretic peptide is associated with post-discharge stroke in hospitalized patients with heart failure.

Yu Hotsuki, Yu Sato, Akiomi Yoshihisa, Koichiro Watanabe, Yusuke Kimishima, Takatoyo Kiko, Tetsuro Yokokawa, Satoshi Abe, Tomofumi Misaka, Takamasa Sato and 6 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Yu HotsukiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yu SatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Akiomi YoshihisaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Koichiro WatanabeDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yusuke KimishimaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takatoyo KikoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Tetsuro YokokawaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Satoshi AbeDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Tomofumi MisakaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takamasa SatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Masayoshi OikawaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Atsushi KobayashiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takayoshi YamakiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Hiroyuki KuniiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Kazuhiko NakazatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yasuchika TakeishiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Fukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsRecently, B-type natriuretic peptide (BNP) has been attracting attention as a predictor of stroke in patients with atrial fibrillation or those with prior stroke experience. However, the association between BNP and stroke has not been examined in patients with chronic heart failure (CHF). In the current study, we assessed whether BNP is associated with future occurrence of stroke in patients with CHF. METHODS AND

resultsWe prospectively studied 1803 consecutive patients who were admitted for decompensated HF and assessed the predictive value of circulating BNP levels for occurrence of post-discharge stroke. A total of 69 (3.8%) patients experienced a stroke (the stroke group) during the post-discharge follow-up period of a median of 1150 days. The stroke group showed a higher CHADS

conclusionsThe assessment of BNP may predict the occurrence of stroke in CHF patients used alone or in combination with established CHADS

Indexed as

Heart FailureStrokeAftercareHumansNatriuretic Peptide, BrainPatient DischargePrognosisNatriuretic Peptide, BrainB-type natriuretic peptideCHADS2 scoreHeart failureStroke

Identifiers

PMID32558327
PMCPMC7524219
OpenAlexW3035822866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.